Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depressive mixed state: testing different definitions.

F Benazzi1

  • 1Department of Psychiatry, National Health Service, Forli, Italy. f.benazzi@fo.nettuno.it

Psychiatry and Clinical Neurosciences
|December 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of severe depression in private practice depressed outpatients.

International journal of psychiatry in clinical practice·2014
Same author

Non-reactive mood in outpatient depression: A 557-case study.

International journal of psychiatry in clinical practice·2014
Same author

Psychotic depression in private practice outpatients.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

On-line estimation and detection of abnormal substrate concentrations in WWTPs using a software sensor: a benchmark study.

Environmental technology·2007
Same author

Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality.

Acta psychiatrica Scandinavica. Supplementum·2007
Same author

Does temperamental instability support a continuity between bipolar II disorder and major depressive disorder?

European psychiatry : the journal of the Association of European Psychiatrists·2006
Same journal

The bodily self in fibromyalgia: A systematic review and meta-analysis of body image, body representation, and interoceptive dysfunction.

Psychiatry and clinical neurosciences·2026
Same journal

Response to commentary "Hypnotic-associated falls across the diurnal cycle: Pharmacokinetic signal or delirium rhythm?"

Psychiatry and clinical neurosciences·2026
Same journal

Characterizing social motivation deficits in treatment-resistant schizophrenia: Evidence from social incentive performance.

Psychiatry and clinical neurosciences·2026
Same journal

Response to [Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia].

Psychiatry and clinical neurosciences·2026
Same journal

Association between initial 30-day cumulative clozapine dose and risk of agranulocytosis: A nationwide register-based cohort study.

Psychiatry and clinical neurosciences·2026
Same journal

Safety and tolerance of oral ketamine: A systematic review.

Psychiatry and clinical neurosciences·2026
See all related articles

Defining depressive mixed state (DMX) with three or more hypomanic symptoms (DMX3) better identifies bipolar II disorder compared to DMX with two or more symptoms (DMX2). This finding has clinical implications for diagnosing and treating DMX.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Mood Disorders

Background:

  • Depressive mixed state (DMX) is characterized by a major depressive episode (MDE) with concurrent hypomanic symptoms.
  • Accurate definition of DMX is crucial for appropriate diagnosis and treatment, especially differentiating unipolar and bipolar disorders.

Purpose of the Study:

  • To evaluate and compare two distinct definitions of DMX based on the number of concurrent hypomanic symptoms.
  • To determine which DMX definition demonstrates a stronger association with bipolar II disorder.

Main Methods:

  • A cohort of 168 unipolar and bipolar II outpatients with MDE were assessed using the DSM-IV Structured Clinical Interview.
  • DMX was defined as MDE with two or more (DMX2) or three or more (DMX3) hypomanic symptoms.

Related Experiment Videos

Main Results:

  • DMX2 was present in 71.8% of bipolar II and 41.5% of unipolar patients.
  • DMX3 was present in 46.6% of bipolar II and 7.6% of unipolar patients (P < 0.01).
  • DMX3 showed a stronger association with bipolar II disorder (odds ratio 10.4) compared to DMX2 (odds ratio 3.5).

Conclusions:

  • The definition of DMX requiring three or more hypomanic symptoms (DMX3) appears to be a more robust indicator for identifying bipolar II disorder.
  • Findings underscore the importance of carefully assessing hypomanic symptoms in patients with depression to guide diagnosis and treatment, as antidepressants may exacerbate DMX.